Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

25 collaborators·62 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Beth Israel Deaconess Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Victor Navarro, MD

Thomas Jefferson University

Similar
3 trials

Shared therapeutic areas:

Hepatitis C, ChronicHepatitis CNon-alcoholic Fatty Liver Disease+1 more

Worked with same sponsors:

Beth Israel Deaconess Medical CenterBrooke Army Medical Center+8 more
Collaborated on 3 trials
Similarity Score52%

K. Rajender Reddy, MD

University of Pennsylvania

Similar
3 trials

Shared therapeutic areas:

Hepatitis C, ChronicHepatitis CNon-alcoholic Fatty Liver Disease+1 more

Worked with same sponsors:

Beth Israel Deaconess Medical CenterBrooke Army Medical Center+8 more
Collaborated on 3 trials
Similarity Score52%

Stephen A. Harrison, MD

Brooke Army Medical Center

Moderately Similar
16 trials

Shared therapeutic areas:

Nonalcoholic SteatohepatitisHepatitis CHepatitis C, Chronic+1 more

Worked with same sponsors:

Beth Israel Deaconess Medical CenterBrooke Army Medical Center+6 more
Collaborated on 1 trial
Similarity Score44%

Marc G Ghany, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Moderately Similar
14 trials

Shared therapeutic areas:

Hepatitis C, ChronicHepatitis CNon-alcoholic Fatty Liver Disease+1 more

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)University of Pennsylvania
Similarity Score30%

Michael Fried, MD

University of North Carolina, Chapel Hill

Related
2 trials

Shared therapeutic areas:

Hepatitis C, ChronicNonalcoholic Steatohepatitis

Worked with same sponsors:

Beth Israel Deaconess Medical CenterBrooke Army Medical Center+8 more
Collaborated on 2 trials
Similarity Score28%

Michael Fried, MD

University of North Carolina

Related
1 trials

Shared therapeutic areas:

Hepatitis CNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Center for Complementary and Integrative Health (NCCIH)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

Raymond Chung, MD

Massachusetts General Hospital

Related
6 trials

Shared therapeutic areas:

Hepatitis CHepatitis C, Chronic

Worked with same sponsors:

Romark Laboratories L.C.
Collaborated on 1 trial
Similarity Score24%

Shih-Jer Hsu, MD

National Taiwan University Hospital, Yun-Lin Branch

Related
5 trials

Shared therapeutic areas:

Hepatitis CHepatitis C, Chronic
Similarity Score15%

Cheng-Chao Liang, MD

Far Eastern Memorial Hospital

Related
6 trials

Shared therapeutic areas:

Hepatitis C, ChronicHepatitis C
Similarity Score15%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Hepatitis C, ChronicHepatitis C
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT00136214PrincipalInvestigator

Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects

Hepatitis C
Completed
NCT00389376Phase 1PrincipalInvestigator

Phase I Trial of Silymarin for Chronic Liver Diseases

Hepatitis CNon-Alcoholic Fatty Liver Disease
Completed
NCT00637923Phase 2PrincipalInvestigator

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

Chronic Hepatitis C
Completed
NCT00680342Phase 2PrincipalInvestigator

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment

Chronic Hepatitis C
Completed
NCT00680407Phase 2PrincipalInvestigator

Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis

Non-alcoholic Steatohepatitis
Completed

All 5 trials loaded